News

Mild CKD Ups Risks of Renal, Urothelial Cancers


 

FROM THE GENITOURINARY CANCERS SYMPOSIUM

The Genitourinary Cancers Symposium is sponsored by the American Society of Clinical Oncology, the American Society for Radiation Oncology, and the Society of Urologic Oncology.

Dr. Lowrance disclosed that he had no relevant conflicts of interest. Dr. Hutson disclosed that he is a consultant to and receives honoraria from Bayer, Genentech, GlaxoSmithKline, Novartis, Onyx, Pfizer, and Wyeth, and that he receives research funding from GlaxoSmithKline, Pfizer, and Wyeth.

Pages

Recommended Reading

Gastric Cancer Subtype May Affect Bevacizumab Benefit
MDedge Family Medicine
Bevacizumab Boosts Treatment Responses in Early Breast Cancer
MDedge Family Medicine
Oral HPV Infection More Prevalent in Men Than Women
MDedge Family Medicine
Cancer Screening Falls Short of Federal Targets
MDedge Family Medicine
Head/Neck Cancer Treatments Less Effective in HIV Patients
MDedge Family Medicine
Re-Excision Rates After Breast-Conserving Surgery Vary Greatly
MDedge Family Medicine
ASCO GU to Spotlight Prostate Cancer Drugs MDV3100 and Radium-223
MDedge Family Medicine
Breast Cancer Drug Exemestane Linked to BMD Loss
MDedge Family Medicine
Breast Cancer Mortality Rises with Age in Older Women
MDedge Family Medicine
FDA Panel Rejects Denosumab Against Bone Metastasis in Prostate Cancer
MDedge Family Medicine